Global Chemotherapy Devices Market Overview:
Chemotherapy device is a point-of-care and implantable devices for cancer treatment to destroy rapidly growing cells in the body. Rapid innovations in chemotherapy devices and technological advancement have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines. According to National Cancer Institutes, an estimated 1,735,350 new cases of cancer will be diagnosed in the United States and 609,640 people will die from the disease in the year 2018. Some of the key players profiled in the study are ICU Medical (United States), Becton, Dickinson and Company (United States), Terumo Corporation (Japan), B. Braun (Germany), Halyard Health (United States), Smiths Group (United Kingdom), Baxter International (United States), Fresenius (Germany), Moog Inc. (United States), Zyno Medical (United States), Micrel Medical (Greece) and Advanced Chemotherapy Technologies (United States).
On the basis of geography, the market of Chemotherapy Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Cancer Type, the sub-segment i.e. Blood Cancer will boost the Chemotherapy Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- The Rising Occurrence of Various Types of Cancer Including Sarcoma, Lung Cancer, Lymphoma, Myeloma, and Breast Cancer
- Surging Investment on Research and Development in Oncology
- Increasing Government Initiatives and Technological Advancements in the Chemotherapy Devices
- The Growing Economic Burden of the Disease, Especially among Geriatric Patient Populations
- Unwillingness Showed by Patients to Undergo Chemotherapy
- Rise in Risk of Infection
- Growing Number of Randomized Clinical Trials in Both Developed and Developing Economies
- Lack of Proper Reimbursement Policies in the Developing Countries
- Dearth of Skilled Professionals in Emerging Nations
Target Audience:Chemotherapy Devices Manufacturers, Chemotherapy Devices Distributors/Suppliers, Hospitals, Research Organizations, End-Users, Government Bodies and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Chemotherapy Devices market on the basis of product [LVP (Large Volume Pump), Syringe Pump and Elastomeric Pumps] , application [Hospital & Clinic and Home Care], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Chemotherapy Devices market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Chemotherapy Devices industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Chemotherapy Devices market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.